{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:39:45Z","timestamp":1781768385286,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018368","name":"UnitedHealth Group Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018368","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13300-021-01110-1","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T07:02:32Z","timestamp":1626591752000},"page":"2223-2239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States"],"prefix":"10.1007","volume":"12","author":[{"given":"Kristina S.","family":"Boye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Tokar Erdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Benneyworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matan C.","family":"Dabora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Hankosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angelyn","family":"Bethel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callahan","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Lensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramira","family":"San Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Etemad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,18]]},"reference":[{"issue":"5","key":"1110_CR1","doi-asserted-by":"publisher","first-page":"105951","DOI":"10.1016\/j.ijantimicag.2020.105951","volume":"55","author":"H Li","year":"2020","unstructured":"Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.","journal-title":"Int J Antimicrob Agents"},{"key":"1110_CR2","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID19. 2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 20 Apr 2020."},{"key":"1110_CR3","unstructured":"World Health Organization. Coronavirus disease (COVID-2019) situation reports-90. 2021. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update---2-february-2021. Accessed 05 Feb 2021."},{"issue":"10223","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"7","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/dc20-0660","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43(7):1399\u2013407.","journal-title":"Diabetes Care"},{"key":"1110_CR6","unstructured":"Centers for Disease Control and Prevention. Evidence used to update the list of underlying medical conditions that increase a person\u2019s risk of severe illness from COVID-19. 2020. https:\/\/stacks.cdc.gov\/view\/cdc\/89840. Accessed 30 Aug 2020."},{"issue":"13","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10223","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"7","key":"1110_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med. 2020;180(7):934\u201343.","journal-title":"China JAMA Intern Med"},{"issue":"18","key":"1110_CR10","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775\u20136.","journal-title":"JAMA"},{"key":"1110_CR11","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.","journal-title":"BMJ"},{"issue":"9","key":"1110_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"K Liu","year":"2020","unstructured":"Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133(9):1025\u201331.","journal-title":"Chin Med J (Engl)"},{"issue":"16","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574\u201381.","journal-title":"JAMA"},{"issue":"20","key":"1110_CR14","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"10229","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"1110_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820978399","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, Shang T, Ahn D, et al. How to best protect people with diabetes from the impact of SARS-CoV-2: report of the international COVID-19 and diabetes summit. J Diabetes Sci Technol. 2021. https:\/\/doi.org\/10.1177\/1932296820978399.","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068-1077.e3.","journal-title":"Cell Metab"},{"issue":"4","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/1932296820924469","volume":"14","author":"B Bode","year":"2020","unstructured":"Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813\u201321.","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.2337\/dc20-1506","volume":"43","author":"J Seiglie","year":"2020","unstructured":"Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care. 2020;43(12):2938\u201344.","journal-title":"Diabetes Care"},{"issue":"3","key":"1110_CR20","doi-asserted-by":"publisher","first-page":"bnaa011","DOI":"10.1210\/endrev\/bnaa011","volume":"41","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):bnaa011.","journal-title":"Endocr Rev"},{"issue":"6","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","volume":"8","author":"SR Bornstein","year":"2020","unstructured":"Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"12","key":"1110_CR24","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258\u201367.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1110_CR25","first-page":"721","volume":"18","author":"HY Chang","year":"2012","unstructured":"Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care. 2012;18(11):721\u20136.","journal-title":"Am J Manag Care"},{"issue":"6","key":"1110_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jdiacomp.2017.02.018","volume":"31","author":"WP Glasheen","year":"2017","unstructured":"Glasheen WP, Renda A, Dong Y. Diabetes Complications Severity Index (DCSI)-update and ICD-10 translation. J Diabetes Complicat. 2017;31(6):1007\u201313.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"1110_CR27","first-page":"15","volume":"14","author":"BA Young","year":"2008","unstructured":"Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14(1):15\u201323.","journal-title":"Am J Manag Care"},{"key":"1110_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York: Pringer; 2009.","edition":"2"},{"key":"1110_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u20135.","journal-title":"Int J Infect Dis"},{"key":"1110_CR30","doi-asserted-by":"publisher","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.","journal-title":"BMJ"},{"issue":"10","key":"1110_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","volume":"8","author":"N Holman","year":"2020","unstructured":"Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1110_CR32","unstructured":"Centers for Disease Control and Prevention (CDC). People with certain medical conditions. 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html. Accessed 13 Jan 2021."},{"key":"1110_CR33","doi-asserted-by":"publisher","first-page":"108268","DOI":"10.1016\/j.diabres.2020.108268","volume":"165","author":"AK Singh","year":"2020","unstructured":"Singh AK, Singh R. Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? Diabetes Res Clin Pract. 2020;165:108268.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1110_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2020.11.014","volume":"33","author":"B Yu","year":"2021","unstructured":"Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33(1):65-77.e2.","journal-title":"Cell Metab"},{"key":"1110_CR35","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3389\/fimmu.2018.01236","volume":"9","author":"F Ursini","year":"2018","unstructured":"Ursini F, Russo E, Pellino G, et al. Metformin and autoimmunity: a \u201cNew Deal\u201d of an old drug. Front Immunol. 2018;9:1236.","journal-title":"Front Immunol"},{"key":"1110_CR36","doi-asserted-by":"publisher","first-page":"108183","DOI":"10.1016\/j.diabres.2020.108183","volume":"164","author":"S Sharma","year":"2020","unstructured":"Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract. 2020;164:108183.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"1110_CR37","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1093\/cid\/ciaa1592","volume":"72","author":"J Xu","year":"2021","unstructured":"Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B. The effect of prior ACEI\/ARB treatment on COVID-19 susceptibility and outcome: a systematic review and meta-analysis. Clin Infect Dis. 2021;72(11):e901\u201313.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1110_CR38","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","volume":"4","author":"R Baral","year":"2021","unstructured":"Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, Vassiliou VS. Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(3):e213594.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1110_CR39","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s12325-021-01704-y","volume":"38","author":"M Cugno","year":"2021","unstructured":"Cugno M, Gualtierotti R, Casazza G, Tafuri F, Ghigliazza G, Torri A, et al. Mortality in PATIENTS with COVID-19 on renin angiotensin system inhibitor long-term treatment: an observational study showing that things are not always as they seem. Adv Ther. 2021;38(5):2709\u201316.","journal-title":"Adv Ther"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01110-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:02:14Z","timestamp":1628157734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,18]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01110-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,18]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}